Verwandte Artikel zu Nuclear Imaging in Drug Discovery, Development, and...
Inhaltsangabe
It is the purpose and business of the pharmaceutical industry to dis- cover, develop, and make available drugs for the care of the sick. The purpose of universities and national laboratories is to provide people and scientific knowledge that can help in the process. This book presents the combined efforts of scientists from the drug in- dustry, academic laboratories and national laboratories to describe advances in radiotracer technology in studies on experimental ani- mals and living human beings. The authors believe that the technol- ogy is now ready for widespread application in the pharmaceutical industry. The goal of this book is to help bring this about. The field of Nuclear Medicine is based on the concept that, if treatment of disease is chemical, the patient's diagnosis should be chemical. Anatomy and histopathology have been the principle ba- sis for making a diagnosis. Histopathologic data suffer from being descriptive, subjective, not quantifiable, and based on the study of dead tissue. The era of histopathology as the dominant concept in medical practice is coming to an end. Histopathologic findings are often heterogeneous and a single biopsy will at times not reveal the true nature of the disease, such as the grading of malignancy. Far greater accuracy of staging of disease and in the planning of treat- ment is possible through chemistry, as well as by making possible a more suitable selection of a histological biopsy site.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor
It is the purpose and business of the pharmaceutical industry to dis cover, develop, and make available drugs for the care of the sick. The purpose of universities and national laboratories is to provide people and scientific knowledge that can help in the process. This book presents the combined efforts of scientists from the drug in dustry, academic laboratories and national laboratories to describe advances in radiotracer technology in studies on experimental ani mals and living human beings. The authors believe that the technol ogy is now ready for widespread application in the pharmaceutical industry. The goal of this book is to help bring this about. The field of Nuclear Medicine is based on the concept that, if treatment of disease is chemical, the patient's diagnosis should be chemical. Anatomy and histopathology have been the principle ba sis for making a diagnosis. Histopathologic data suffer from being descriptive, subjective, not quantifiable, and based on the study of dead tissue. The era of histopathology as the dominant concept in medical practice is coming to an end. Histopathologic findings are often heterogeneous and a single biopsy will at times not reveal the true nature of the disease, such as the grading of malignancy. Far greater accuracy of staging of disease and in the planning of treat ment is possible through chemistry, as well as by making possible a more suitable selection of a histological biopsy site.
Reseña del editor
Explores the application of nuclear imaging as a research tool for use by pharmaceutical and biotechnology companies to aid in drug discovery, development and the approval of new pharmaceuticals.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Neu kaufen
Diesen Artikel anzeigen
EUR 63,70
Gratis für den Versand innerhalb von/der USA
Versandziele, Kosten & DauerWeitere beliebte Ausgaben desselben Titels
Suchergebnisse für Nuclear Imaging in Drug Discovery, Development, and...
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development, and Approval
Anbieter: Ammareal, Morangis, Frankreich
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: Très bon. Ancien livre de bibliothèque avec équipements. Edition 1993. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 1993. Ammareal gives back up to 15% of this item's net price to charity organizations. Bestandsnummer des Verkäufers F-979-759
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development, and Approval
Anbieter: Romtrade Corp., STERLING HEIGHTS, MI, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Bestandsnummer des Verkäufers ABNR-89223
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development, and Approval
Anbieter: Basi6 International, Irving, TX, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Bestandsnummer des Verkäufers ABEOCT25-122373
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development and Approval
Anbieter: Books Puddle, New York, NY, USA
Verkäuferbewertung 4 von 5 Sternen
Zustand: New. pp. 339 1st Edition. Bestandsnummer des Verkäufers 26457387
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development and Approval
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. pp. 339. Bestandsnummer des Verkäufers 7423348
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Nuclear Imaging in Drug Discovery, Development and Approval
Anbieter: Biblios, Frankfurt am main, HESSE, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. pp. 339. Bestandsnummer des Verkäufers 18457377
Anzahl: 1 verfügbar